ATE419331T1 - L. salivarius-stamm enthaltende probiotische produkte - Google Patents
L. salivarius-stamm enthaltende probiotische produkteInfo
- Publication number
- ATE419331T1 ATE419331T1 AT01958512T AT01958512T ATE419331T1 AT E419331 T1 ATE419331 T1 AT E419331T1 AT 01958512 T AT01958512 T AT 01958512T AT 01958512 T AT01958512 T AT 01958512T AT E419331 T1 ATE419331 T1 AT E419331T1
- Authority
- AT
- Austria
- Prior art keywords
- lactic acid
- acid bacteria
- probiotics
- digestive tract
- effective component
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title abstract 5
- 235000018291 probiotics Nutrition 0.000 title abstract 5
- 241000186869 Lactobacillus salivarius Species 0.000 title abstract 3
- 230000000529 probiotic effect Effects 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 6
- 241000894006 Bacteria Species 0.000 abstract 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 3
- 235000014655 lactic acid Nutrition 0.000 abstract 3
- 239000004310 lactic acid Substances 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000004400 mucous membrane Anatomy 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 210000000056 organ Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000254775 | 2000-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE419331T1 true ATE419331T1 (de) | 2009-01-15 |
Family
ID=18743660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01958512T ATE419331T1 (de) | 2000-08-25 | 2001-08-27 | L. salivarius-stamm enthaltende probiotische produkte |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7150986B2 (de) |
| EP (1) | EP1312667B1 (de) |
| JP (1) | JP3944076B2 (de) |
| AT (1) | ATE419331T1 (de) |
| AU (1) | AU2001280178A1 (de) |
| DE (1) | DE60137235D1 (de) |
| ES (1) | ES2316463T3 (de) |
| SI (1) | SI1312667T1 (de) |
| WO (1) | WO2002016554A1 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
| ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| DK1498039T3 (da) * | 2002-03-29 | 2012-10-15 | Frente Internat Co Ltd | Vitale cellepræparater, som indeholder mælkesyrebakterie som aktivt stof, og mælkesyrebakterieholdige fødevareprodukter |
| JP4212838B2 (ja) * | 2002-06-26 | 2009-01-21 | カルピス株式会社 | 抗アレルギー剤 |
| JP2005013211A (ja) * | 2002-09-27 | 2005-01-20 | Wakamoto Pharmaceut Co Ltd | 乳酸菌含有食品組成物 |
| FR2848115B1 (fr) * | 2002-12-05 | 2005-03-25 | Rhodia Chimie Sa | Composition de bacteries et son utilisation |
| US20050281756A1 (en) * | 2004-06-14 | 2005-12-22 | Eamonn Connolly | Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| US20040197304A1 (en) | 2003-04-01 | 2004-10-07 | The Procter & Gamble Company And Alimentary Health, Ltd. | Methods of determining efficacy of treatments of inflammatory diseases of the bowel |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
| US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
| US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
| US7256202B2 (en) * | 2003-12-31 | 2007-08-14 | Halow George M | Composition and method for treatment of hepatic encephalopathy |
| FR2869622B1 (fr) * | 2004-04-28 | 2008-04-18 | Rhodia Chimie Sa | Comprimes de micro-organismes pour ensemencement direct |
| EP1634948A1 (de) | 2004-09-10 | 2006-03-15 | Basf Aktiengesellschaft | Mittel und Verfahren zur Vorbeugung und/oder Behandlung von Karies |
| EP2261323A1 (de) | 2005-05-31 | 2010-12-15 | The Iams Company | Probiotische Katzen-Laktobazillen |
| CA2607949C (en) | 2005-05-31 | 2012-09-25 | Thomas William-Maxwell Boileau | Feline probiotic bifidobacteria |
| US20100047190A1 (en) * | 2006-12-19 | 2010-02-25 | Basf Se | Uses and methods for preventing and/or treating caries caused by mutants streptococci |
| CA2673465A1 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal |
| WO2008134450A2 (en) * | 2007-04-24 | 2008-11-06 | Kemin Industries, Inc. | Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115 |
| PL210465B1 (pl) * | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Zastosowanie kompozycji szczepów z rodzaju Lactobacillus |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| EP2133414A1 (de) | 2008-06-11 | 2009-12-16 | Basf Se | Anwendungen und Verfahren zur Vorbeugung und/oder Behandlung von Mundgeruch |
| JP5645192B2 (ja) * | 2009-07-16 | 2014-12-24 | 国立大学法人広島大学 | 口腔内疾患の予防、改善又は治療剤 |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| EP2485744A4 (de) * | 2009-10-09 | 2014-01-22 | Prothera Inc | Zusammensetzungen und verfahren mit pediokokken zur reduzierung mindestens eines symptoms für autismusspektrumserkrankungen bei einem patienten mit diagnostizierter autismusspektrumserkrankung |
| TWI384990B (zh) * | 2010-01-15 | 2013-02-11 | Glact Biotech Co Ltd | 用於治療胃潰瘍之乳酸菌菌株之食品組成物以及醫藥組成物 |
| JP2012092094A (ja) * | 2010-09-30 | 2012-05-17 | Wakamoto Pharmaceutical Co Ltd | 油脂中に乳酸菌を含有する口腔用組成物 |
| KR101062555B1 (ko) * | 2011-01-11 | 2011-09-06 | 광주시농업기술센터 | 축산용 생균제 조성물 및 그 제조방법 |
| JP5468183B2 (ja) | 2011-12-28 | 2014-04-09 | 株式会社山田養蜂場本社 | ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途 |
| KR101381794B1 (ko) * | 2012-04-10 | 2014-04-07 | 씨제이제일제당 (주) | 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물 |
| FR2999601B1 (fr) | 2012-12-17 | 2015-01-30 | Urgo Lab | Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis |
| HUE060892T2 (hu) * | 2013-07-05 | 2023-04-28 | Stellar Biome Inc | Probiotikus baktériumtörzsek a szájüreg betegségeinek megelõzésére és kezelésére |
| TWI581791B (zh) * | 2013-10-01 | 2017-05-11 | 行政院國軍退除役官兵輔導委員會高雄榮民總醫院 | 六羥季銨鹽類治療哺乳動物腸病毒７１型腦炎的用途 |
| TWI577380B (zh) * | 2015-01-14 | 2017-04-11 | Lactic acid bacteria composition for the treatment of gastrointestinal disorders | |
| JP6236052B2 (ja) * | 2015-11-16 | 2017-11-22 | 欽也 斉藤 | 口内虫歯予防粉及び口内虫歯予防粉の製造方法 |
| JP6190512B1 (ja) * | 2016-10-27 | 2017-08-30 | 肇 福永 | Ｍ細胞を制御する乳酸菌の生成方法 |
| EP3517119B1 (de) | 2018-01-26 | 2021-08-11 | Probisearch, S.L.U. | Zusammensetzung mit neuem lactobacillus salivarius-stamm und verfahren zur vorbeugung und behandlung von ohrenentzündung und infektionen der oberen atemwege |
| CN109486700A (zh) * | 2018-08-31 | 2019-03-19 | 石家庄君乐宝乳业有限公司 | 副干酪乳杆菌n1115预防结肠炎的应用及相应的益生菌粉、应用 |
| KR102251294B1 (ko) * | 2018-11-06 | 2021-05-12 | 주식회사 메디뉴트롤 | 락토바실러스 살리바리우스 v133 균주의 사균체를 유효성분으로 함유하는 알코올성 위염의 예방, 개선 또는 치료용 조성물 |
| CN110923172B (zh) * | 2019-12-25 | 2023-05-09 | 江西仁仁健康微生态科技有限公司 | 一株具有通便功效和降胆固醇功效的唾液乳杆菌及应用 |
| CN115466699B (zh) * | 2022-09-28 | 2023-03-31 | 成都大熊猫繁育研究基地 | 熊猫源唾液乳杆菌及在治疗或预防炎症性肠病中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3581091D1 (de) * | 1984-03-09 | 1991-02-07 | Advance Kk | Anti-karies- oder anti-periodontitismittel. |
| JP4021951B2 (ja) * | 1996-03-01 | 2007-12-12 | わかもと製薬株式会社 | 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品 |
| IT1289984B1 (it) * | 1997-02-27 | 1998-10-19 | Proge Farm Srl | Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale |
| DE69802260T2 (de) * | 1998-04-30 | 2002-07-04 | Vesely Renata Maria Cavaliere | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen |
| ID30071A (id) * | 1998-12-11 | 2001-11-01 | Urex Biotech Inc | Pemberian oral lactobacillus untuk pengobatan dan pencegahan infeksi urogental |
| JP4603116B2 (ja) * | 1999-12-02 | 2010-12-22 | わかもと製薬株式会社 | 乳酸菌含有組成物、医薬及び食品 |
-
2001
- 2001-08-27 WO PCT/JP2001/007312 patent/WO2002016554A1/ja active Application Filing
- 2001-08-27 AT AT01958512T patent/ATE419331T1/de not_active IP Right Cessation
- 2001-08-27 ES ES01958512T patent/ES2316463T3/es not_active Expired - Lifetime
- 2001-08-27 JP JP2002522228A patent/JP3944076B2/ja not_active Expired - Lifetime
- 2001-08-27 DE DE60137235T patent/DE60137235D1/de not_active Expired - Lifetime
- 2001-08-27 EP EP01958512A patent/EP1312667B1/de not_active Expired - Lifetime
- 2001-08-27 AU AU2001280178A patent/AU2001280178A1/en not_active Abandoned
- 2001-08-27 SI SI200130897T patent/SI1312667T1/sl unknown
-
2003
- 2003-02-25 US US10/372,323 patent/US7150986B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7150986B2 (en) | 2006-12-19 |
| EP1312667A4 (de) | 2005-01-19 |
| DE60137235D1 (de) | 2009-02-12 |
| SI1312667T1 (sl) | 2009-04-30 |
| ES2316463T3 (es) | 2009-04-16 |
| WO2002016554A9 (fr) | 2002-03-28 |
| EP1312667A1 (de) | 2003-05-21 |
| US20030157079A1 (en) | 2003-08-21 |
| WO2002016554A1 (fr) | 2002-02-28 |
| EP1312667B1 (de) | 2008-12-31 |
| AU2001280178A1 (en) | 2002-03-04 |
| JP3944076B2 (ja) | 2007-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60137235D1 (de) | L. salivarius-Stamm enthaltende probiotische Produkte | |
| ATE407687T1 (de) | Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids | |
| Fernández et al. | Probiotic properties of native Lactobacillus spp. strains for dairy calves | |
| KR101255894B1 (ko) | 락토바실러스 플란타룸 및 그의 용도 | |
| HUP0100428A2 (hu) | Lactobacillus paracasei subsp. paracasei fajhoz tartozó baktériumtörzs, abból élelmiszeripari alkalmazás céljára előállított készítmények, valamint a baktériumtörzset tartalmazó termékek | |
| SE0402406L (sv) | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa | |
| ATE323503T1 (de) | Bacillus coagulans-zusammensetzung und deren verwendung | |
| TW200514847A (en) | Lactic acid bacteria having mucosal immunopotentiation effect | |
| HUP0200205A2 (hu) | Tejsavbaktérium-törzsek hasmenés megelőzésére | |
| WO2001058465A3 (en) | Probiotic therapy for newborns | |
| DE69924141D1 (de) | Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen | |
| BR0315209A (pt) | Formulações nutritivas que contêm substâncias simbióticas | |
| WO2002083879A3 (en) | Immunotherapy based on dendritic cells | |
| WO2000007606A3 (en) | Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria | |
| BR0314511A (pt) | Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater | |
| ATE354964T1 (de) | Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen | |
| DE69622855D1 (de) | Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten | |
| ATE433670T1 (de) | Futtermittelzusammensetzung | |
| WO2003053474A3 (en) | Use of micro-organisms for a directed delivery of substances to specific parts of the gut | |
| MY140870A (en) | Nutrition supplement containing lactobacillus acidophilus, yeast and soy protein | |
| Singroha et al. | Isolation and characterization of potential probiotic Lactobacillus gasseri strains isolated from different sources | |
| Etebarian et al. | Oral Lactobacillus species and their probiotic capabilities in patients with periodontitis and periodontally healthy individuals | |
| ATE291353T1 (de) | Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen | |
| Xu et al. | Antibiotic susceptibility of potential probiotic Lactobacilli isolated from the vagina of Chinese pregnant women | |
| DE60012521D1 (de) | BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |